Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Finn

Showing results (141-150 of 235) with videos related to

Pageof 24
Sort By:
Expert Review of Vaccines|March 5, 2025
How to improve pertussis vaccination in pregnancy: a European expert reviewAdam Finn, Nicole Guiso, Carl Heinz Wirsing von König, et al.
Vaccine|April 11, 2017
Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13Johannes Trück, Amber Thompson, Begonia Morales-Aza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
Impact of Meningococcal B (4CMenB) Vaccine on Pharyngeal Neisseria meningitidis Carriage Density and Persistence in AdolescentsMark McMillan, Luke Walters, Thomas Sullivan, et al.
Vaccine|December 29, 2016
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancyDavid Pace, Ameneh Khatami, Simon Attard-Montalto, et al.
BMJ Open|September 12, 2024
Developing films to support vaccine-hesitant, ethnically diverse parents' decision-making about the human papillomavirus (HPV) vaccine: a codesign studyHarriet Fisher, Sarah Denford, Tracey Chantler, et al.
BMC Public Health|January 4, 2024
Information needs of ethnically diverse, vaccine-hesitant parents during decision-making about the HPV vaccine for their adolescent child: a qualitative studyHarriet Fisher, Sarah Denford, Suzanne Audrey, et al.
BMC Microbiology|April 27, 2024
High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and IrelandJuan Pablo Rodriguez-Ruiz, Basil Britto Xavier, Wolfgang Stöhr, et al.
The Lancet. Infectious Diseases|September 8, 2022
Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trialRajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, et al.
BMJ (Clinical Research Ed.)|January 24, 2020
Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare dataHarriet Forbes, Ian Douglas, Adam Finn, et al.
Nature Communications|April 25, 2024
Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection riskAllen Haddrell, Henry Oswin, Mara Otero-Fernandez, et al.
Pageof 24

Showing results (141-150 of 235) with videos related to

Sort By:
Pageof 24
Expert Review of Vaccines|March 5, 2025
How to improve pertussis vaccination in pregnancy: a European expert reviewAdam Finn, Nicole Guiso, Carl Heinz Wirsing von König, et al.
Vaccine|April 11, 2017
Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13Johannes Trück, Amber Thompson, Begonia Morales-Aza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
Impact of Meningococcal B (4CMenB) Vaccine on Pharyngeal Neisseria meningitidis Carriage Density and Persistence in AdolescentsMark McMillan, Luke Walters, Thomas Sullivan, et al.
Vaccine|December 29, 2016
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancyDavid Pace, Ameneh Khatami, Simon Attard-Montalto, et al.
BMJ Open|September 12, 2024
Developing films to support vaccine-hesitant, ethnically diverse parents' decision-making about the human papillomavirus (HPV) vaccine: a codesign studyHarriet Fisher, Sarah Denford, Tracey Chantler, et al.
BMC Public Health|January 4, 2024
Information needs of ethnically diverse, vaccine-hesitant parents during decision-making about the HPV vaccine for their adolescent child: a qualitative studyHarriet Fisher, Sarah Denford, Suzanne Audrey, et al.
BMC Microbiology|April 27, 2024
High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and IrelandJuan Pablo Rodriguez-Ruiz, Basil Britto Xavier, Wolfgang Stöhr, et al.
The Lancet. Infectious Diseases|September 8, 2022
Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trialRajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, et al.
BMJ (Clinical Research Ed.)|January 24, 2020
Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare dataHarriet Forbes, Ian Douglas, Adam Finn, et al.
Nature Communications|April 25, 2024
Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection riskAllen Haddrell, Henry Oswin, Mara Otero-Fernandez, et al.
Pageof 24